Purpose: Mesenchymal stem cells (MSCs) enhance regeneration when locally delivered in
pre-clinical models of osteoarthritis (OA). Their mechanism of action, however, is still poorly …

Purpose: Osteoarthritis (OA) is one of the leading causes of decreased athletic performance
in people and horses. Treatment with autologous mesenchymal stem cells (MSCs) has been …

We evaluated the therapeutic effect of human adipose tissue-derived mesenchymal stem
cells (hAd-MSCs) in a SKG arthritis model, a relevant animal model for human rheumatoid …

In the present study, the effects and mechanisms of mesenchymal stem cells (MSCs) on
interleukin (IL)-1β‑stimulated rat chondrocytes, as well as cartilage from a rat model of …

Background Synovial fluid mesenchymal stem cells (SF-MSCs) originate in the synovium
and contribute to the endogenous repair of damaged intra-articular tissues. Here, we …

Mesenchymal stem cell (MSC) therapy represents a promising approach for the treatment of
osteoarthritis (OA). MSCs can be readily isolated from multiple sources and expanded ex …

Despite the immunosuppressive, homing, and regenerative capabilities of mesenchymal
stem cells (MSCs), their ability to migrate to arthritic joints and influence the course of …

Rheumatoid arthritis (RA) is characterised with chronic inflammatory synovitis and
progressive joint. Because damaged and/or deformed joints cannot be repaired, a novel …

Rheumatoid arthritis is a chronic autoimmune disease and affecting approximately 1% of the
population. Human adipose-derived mesenchymal stem cells (hASCs) were recently found …

The possibility to isolate synovial fluid-derived mesenchymal stem cells (SFMSCs) from
patients with degenerative arthropathy has been an interest since synovial fluid (SF) from …